Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONGeneric

ERYTHROMYCIN LACTOBIONATE

ERYTHROMYCIN LACTOBIONATE

Standard Dose
EQ 1GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview ERYTHROMYCIN LACTOBIONATE is listed in Drugs@FDA under application 063253 (ANDA).
  • Marketing status: Discontinued Active ingredient ERYTHROMYCIN LACTOBIONATE Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 1996-05-10 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERYTHROMYCIN LACTOBIONATE is listed in Drugs@FDA under application 063253 (ANDA). Marketing status: Discontinued Active ingredient ERYTHROMYCIN LACTOBIONATE Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor TEVA PARENTERAL Submission history Latest submission status date: 1996-05-10 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.